Priority Date: 09.03.12 (US 201261609069P)

METHODS AND COMPOSITIONS RELATING TO DIAGNOSING AND TREATING RECEPTOR TYROSINE KINASE RELATED CANCERS

  • Application ID: EP13758525
  • Status: GRANT OF PATENT INTENDED

Attorneys

Company dna ch kilger anwaltspartnerschaft mbb
no operation time available
1 office
active in Legal Services
Employment test 11 - 50 employees
Company dna fanelli haag and kilger pllc
operating since 2009
Headquarter in Washington, DC and 1 office
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) CH Kilger Anwaltspartnerschaft mbB and Fanelli Haag & Kilger PLLC are specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 09.03.2012 - Priority Date (US 201261609069P)
  • 12.09.2013 - Publication A1 (WO2013134693)
  • 14.01.2015 - Publication A1 (EP2823065)

IPC Classification